These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 19205731
41. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Gratacòs M, González JR, Mercader JM, de Cid R, Urretavizcaya M, Estivill X. Biol Psychiatry; 2007 Apr 01; 61(7):911-22. PubMed ID: 17217930 [Abstract] [Full Text] [Related]
48. Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males. Cheng CY, Hong CJ, Yu YW, Chen TJ, Wu HC, Tsai SJ. Brain Res Mol Brain Res; 2005 Oct 31; 140(1-2):86-90. PubMed ID: 16109452 [Abstract] [Full Text] [Related]
49. Association between BDNF Val66Met polymorphism and trait depression is mediated via resting EEG alpha band activity. Gatt JM, Kuan SA, Dobson-Stone C, Paul RH, Joffe RT, Kemp AH, Gordon E, Schofield PR, Williams LM. Biol Psychol; 2008 Oct 31; 79(2):275-84. PubMed ID: 18721847 [Abstract] [Full Text] [Related]
52. Illness-specific association of val66met BDNF polymorphism with performance on Wisconsin Card Sorting Test in bipolar mood disorder. Rybakowski JK, Borkowska A, Skibinska M, Hauser J. Mol Psychiatry; 2006 Feb 31; 11(2):122-4. PubMed ID: 16222333 [No Abstract] [Full Text] [Related]
53. An epistasis effect of functional variants on the BDNF and DRD2 genes modulates gray matter volume of the anterior cingulate cortex in healthy humans. Montag C, Weber B, Jentgens E, Elger C, Reuter M. Neuropsychologia; 2010 Mar 31; 48(4):1016-21. PubMed ID: 19961866 [Abstract] [Full Text] [Related]